Cornell team identifies first molecular case of Marfan syndrome in domestic cats

Key points

• Two cats, Gary and Shaggy, exhibited classic Marfan syndrome symptoms including long limbs, lens luxation, and aortic dilation.
• Whole genome sequencing revealed a homozygous variant in the FBN1 gene, specifically a splice region change upstream of exon 22.
• The variant caused exon skipping in 73% of transcripts, but a 'leaky' splice site allowed enough normal protein production for the cats to survive to adulthood.
• The study involved a multidisciplinary team from Cornell, Ghent University, the University of Pennsylvania, and the Schwarzman Animal Medical Center.
• This finding provides a foundation for future veterinary diagnostics and genetic testing for connective tissue disorders in cats.

Background

Marfan syndrome is a rare autosomal dominant connective tissue disorder affecting approximately 1 in 4,000 people, primarily characterized by defects in the fibrillin-1 protein. While well-studied in humans, spontaneous animal models have rarely been reported. Recent veterinary research has focused on other feline genetic conditions, such as kidney lipid signatures and avian flu tracking, but this is the first time Marfan syndrome has been molecularly characterized in cats.

How outlets are covering it

The primary source, Scientific Reports, emphasizes the molecular mechanism, detailing how the homozygous variant in the FBN1 gene leads to exon 22 skipping in 73% of transcripts, yet allows survival due to a 'leaky' splice site. Secondary sources like Vet Candy and the Cornell Chronicle highlight the clinical journey, noting that the cats' unusually long limbs initially prompted the workup. All sources agree on the rarity of the condition in cats and the collaborative nature of the research, but the academic source focuses on the hypomorphic nature of the variant, while the news outlets stress the potential for improved veterinary diagnostics and the role of pet owners in the discovery process.

Why it matters

This discovery provides a new comparative model for studying Marfan syndrome, offering insights into the genetic and molecular basis of the disease that may not be apparent in human studies. It also highlights the potential for genetic testing in veterinary medicine, allowing for earlier detection and management of connective tissue disorders in cats, which could improve patient outcomes and quality of life.

What to watch

Researchers will likely use this identified variant to develop genetic tests for Marfan syndrome in cats. This could lead to earlier diagnosis and better management of the condition in feline patients. Additionally, the study may prompt further investigation into the prevalence of similar variants in other cat populations and the potential for developing targeted therapies for connective tissue disorders in animals.